Staphylococcus aureus-targeting peptide/surfactant assemblies for antibacterial therapy.

Area of Science:

• Biochemistry
• Materials Science
• Microbiology

Background:

• Microbial resistance to antibiotics poses a significant global health threat.
• Developing novel antimicrobial agents and strategies to overcome resistance is crucial.

Purpose of the Study:

• To develop a novel surfactant-based antimicrobial system to combat resistant bacteria.
• To investigate the dual function of the surfactant as an antibacterial agent and a beta-lactamase inhibitor.

Main Methods:

• Synthesis of an 18-carbon single hydrocarbon chain and multi-amine head group surfactant (C18N3).
• Assembly of C18N3 with a Staphylococcus aureus-targeting peptide (CARG).
• In vitro and in vivo evaluation of antimicrobial activity and beta-lactamase inhibition.

Main Results:

• C18N3/CARG assemblies demonstrated significant antimicrobial activity against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus.
• The targeting peptide CARG ensured specific binding to Staphylococcus aureus.
• C18N3 exhibited noncompetitive inhibition of beta-lactamase, overcoming antibiotic resistance.
• Combination therapy with beta-lactam antibiotics and C18N3/CARG showed enhanced efficacy.

Conclusions:

• The developed antibacterial platform, featuring antibiotic-carrying surfactant assemblies with targeted peptides, offers a promising strategy against difficult-to-treat infections.
• The dual function of C18N3 as an antibacterial agent and beta-lactamase inhibitor is key to its effectiveness.